<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03818971</url>
  </required_header>
  <id_info>
    <org_study_id>RIPH 2018-02</org_study_id>
    <nct_id>NCT03818971</nct_id>
  </id_info>
  <brief_title>Study of Retinal Function Using Electroretinogram in Regular Alcohol Users</brief_title>
  <acronym>ERICA</acronym>
  <official_title>Study of Retinal Function Using Electroretinogram in Regular Alcohol Users</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Psychothérapique de Nancy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Psychothérapique de Nancy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Alcohol is a major public health problem and its neurotoxic effects are, among other things,
      responsible for altering the functioning of cerebral neurotransmission pathways.

      The retina is an anatomical and developmental extension of the central nervous system. It is
      composed of several layers of retinal neurons that share similar anatomical and functional
      properties with brain neurons. Retinal neurons are notably equipped with a complex system of
      neurotransmission constituted by the main neurotransmitters that are involved in the central
      effects of alcohol: glutamate, dopamine, serotonin ... The retina is used here as a site of
      indirect investigation for abnormal central neurotransmission pathways following regular
      alcohol use. It is recognized to date as a good site for investigating central abnormalities
      in neuropsychiatric and addictive disorders.

      The objective of this project is to study the retinal function using electroretinogram (ERG)
      in regular alcohol users to isolate potential markers of cerebral neurotransmission
      abnormalities.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 13, 2019</start_date>
  <completion_date type="Anticipated">July 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>mono centric study, in parallel groups, controlled, non-randomized and open</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>modification of amplitude</measure>
    <time_frame>Day 0 (=day of inclusion = the only visit of the study)</time_frame>
    <description>measured with flash electroretinogram and pattern electroretinogram / amplitude in microvolt</description>
  </primary_outcome>
  <primary_outcome>
    <measure>modification of implicite time parameters</measure>
    <time_frame>Day 0 (=day of inclusion = the only visit of the study)</time_frame>
    <description>measured with flash electroretinogram and pattern electroretinogram - implicite time in millisecond</description>
  </primary_outcome>
  <primary_outcome>
    <measure>modification of amplitude of the oscillatory potential</measure>
    <time_frame>Day 0 (=day of inclusion = the only visit of the study)</time_frame>
    <description>waves P1, P2, P3, P4 measured with flash electroretinogram - amplitude in microvolt</description>
  </primary_outcome>
  <primary_outcome>
    <measure>modification of implicit time of the oscillatory potential</measure>
    <time_frame>Day 0 (=day of inclusion = the only visit of the study)</time_frame>
    <description>waves P1, P2, P3, P4 measured with flash electroretinogram - implicite time in millisecond</description>
  </primary_outcome>
  <primary_outcome>
    <measure>modification of amplitude of the background noise</measure>
    <time_frame>Day 0 (=day of inclusion = the only visit of the study)</time_frame>
    <description>measured with the flash electroretinogram, flicker 3.0 sequence - amplitude in microvolt</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Alcohol Use Disorder</condition>
  <arm_group>
    <arm_group_label>alcohol consumption with alcohol use disorder (AUD)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects with regular alcohol consumption with AUD according to the DSM 5 without any other substance use disorder (except alcohol) without psychiatric, neurologic or ophthalmologic disease in progress with a negative drug check and Breathalyzer the day of the inclusion - only one visit is planned for this study : an electroretinogram will be realized</description>
  </arm_group>
  <arm_group>
    <arm_group_label>alcohol consumption without alcohol use disorder</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>subjects with regular alcohol consumption without AUD according to the DSM 5 without any other substance use disorder without psychiatric, neurologic or ophthalmologic disease in progress with a negative drug check and Breathalyzer the day of the inclusion - only one visit is planned for this study : an electroretinogram will be realized</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no alcohol consumption</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>subjects without alcohol consumption without any other substance use disorder without psychiatric, neurologic or ophthalmologic disease in progress with a negative drug check and Breathalyzer the day of the inclusion - only one visit is planned for this study : an electroretinogram will be realized</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>electroretinogram (flash, pattern and multifocal)</intervention_name>
    <description>we measured the waves a, b, oscillatory potentials, back ground noise and i for the flash ERG, the waves P50 and N95 for the pattern ERG and the P1, N1 and N2 for the multifocal ERG</description>
    <arm_group_label>alcohol consumption with alcohol use disorder (AUD)</arm_group_label>
    <arm_group_label>alcohol consumption without alcohol use disorder</arm_group_label>
    <arm_group_label>no alcohol consumption</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        For alcohol consumer with alcohol use disorder :

        Inclusion Criteria:

          -  aged between 18 and 35 years

          -  alcohol use disorder according to the DSM 5

          -  affiliation to a social security scheme

        Exclusion Criteria:

          -  psychoactive substance consumption (other than alcohol)

          -  psychiatric disease in progress according to the DSM 5

          -  neurologic disease in progress

          -  mental impairment making it difficult or impossible to participate to the study

          -  major under guardianship or curatorship or under safeguarding of justice

          -  pregnant women or feeding

          -  people in emergency situation

          -  participation to another interventional study

          -  retinal disease in progress

          -  chronic glaucoma

          -  ophtalmic disease affecting the visual acuity

          -  ocular infection in progress

          -  urinary positive drug check the day of the inclusion

          -  postive Breathalyser the day of the inclusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas SCHWITZER</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Psychothérapique de Nancy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ludovic POLLI</last_name>
    <phone>+33383925349</phone>
    <email>ludovic.polli@cpn-laxou.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tatiana DABROWSKI</last_name>
    <phone>+33383925349</phone>
    <email>tatiana.dabrowski@cpn-laxou.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Psychothérapique de Nancy</name>
      <address>
        <city>Laxou</city>
        <state>Nancy</state>
        <zip>54520</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas SCHWITZER, MD, PhD</last_name>
      <phone>03 83 92 84 40</phone>
      <email>thomas.schwitzer@univ-lorraine.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>January 10, 2019</study_first_submitted>
  <study_first_submitted_qc>January 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2019</study_first_posted>
  <last_update_submitted>July 19, 2019</last_update_submitted>
  <last_update_submitted_qc>July 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>retina AND electroretinogram</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcoholism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

